心血管

订阅

MedSci主页 / 所有栏目 / 心血管

合集：ASE及AHA/ACC心脏瓣膜病相关指南中文版翻译合集

2017-03-03 MedSci MedSci原创

心脏瓣膜病中文版翻译
关注

当前针对各种疾病，各种技术都有层出不穷的“指南”，“共识”用以规范，指导临床医生的实践，希望能够最好的指导医生为患者做出最适合的抉择。瓣膜病是否也有指南来帮助我们抉择呢？瓣膜病的指南比之其他疾病要少得多，更新的频率也要稀疏得多。下面小编为大家整理了中国专家对ASE及AHA/ACC的心脏瓣膜病相关指南的中文版翻译，以期为临床医生做出抉择时有所帮助。

由于人口的老龄化，老年退行性瓣膜病越来越多。瓣膜病的根本治疗是手术修复或瓣膜置换。然而作为内科医生却常常有很多无奈或困惑。即如何选择手术时机，特别是对老年患者。是应该一旦发现病变、有手术指征者就要尽早手术，以保障生活质量，以免延误了手术时机？还是再等等看，或许老人免了一次手术的创伤还可以维持一定的生活质量很多年呢？ 当前针对各种疾病，各种技术都有层出不穷的“指南”，“共识”用以规范，指导临床医生的实践，希望能够最好的指导医生为患者做出最适合的抉择。瓣膜病是否也有指南来帮助我们抉择呢？瓣膜病的指南比之其他疾病要少得多，更新的频率也要稀疏得多。下面小编为大家整理了中国专家对ASE及AHA/ACC的心脏瓣膜病相关指南的中文版翻译，以期为临床医生做出抉择时有所帮助。

  
一、经导管主动脉瓣植入、二尖瓣修复和人工瓣膜瓣周漏封堵的开展显著扩大导管技术在瓣膜返流和狭窄治疗中的应用范围。超声心动图在确定适于接受这些介入治疗的患者和术中监测中都起到了至关重要的作用。而且它也是介入治疗术后随访最基本的手段。对接受经导管介入治疗患者的评估对于超声心动图提出了有异于自身瓣膜或者人工瓣膜病变患者常规评价的要求。 
  • EAE/ASE 超声心动图在心脏瓣膜病经导管介入治疗新技术中应用的建议
    • 二、本文详细介绍了超声心动图评价瓣膜狭窄的方法，包括数据采集、测量和评估瓣膜狭窄严重程度的具体细节。这些建议都是基于大量临床研究文献的总结，并得到专家小组的认同。 
  • 关于临床实践中应用超声心动图评估瓣膜狭窄的建议
    • 三、本文通过对科学文献的总结及国际专家小组达成的共识，就超声心动图以及多普勒技术评价人工瓣膜功能做一综述，作为评价人工瓣膜的指南。 
  • 关于超声心动图及多普勒超声评价人工瓣膜的建议
    • 四、本文详细回顾了超声心动图及多普勒技术在评估成人瓣膜反流的应用,依据科研文献及专家达成的共识提供了评估瓣膜反流严重程度的建议。  
  • 关于二维及多普勒超声心动图评估自体瓣膜反流程度的建议
    • 五、美国心脏协会和美国心脏病学会( AHA/ACC)发布的《2014 年心脏瓣膜病患者管理指南》，是自2008 年以来该指南的首次更新，内容囊括了各种类型的获得性成人瓣膜疾病，提供的建议涵盖了疾病分期、诊断、药物治疗及介入( 手术和微创) 治疗。与2008 年指南相比，该指南重要的更新内容之一是更加重视早期干预瓣膜病，降低了干预治疗的门槛，在某种情况下，即使在症状发展之前，一些患者仍可以接受干预治疗。 
  • 2014 年美国心脏瓣膜病指南解读
    • 六、2014年3 月3 日， 美国心脏协会和美国心脏病学会（AHA/ACC）发布了《2014 年心脏瓣膜病患者管理指南》，在该指南中AHA/ACC 首次对心脏瓣膜病的分期、诊断、治疗（包括药物、手术及介入治疗）及管理等给出指导，并更新部分推荐意见。在这里，我们对新指南几个要点解读的同时， 着重分析新指南对主动脉瓣膜病的处理。 
  • 主动脉瓣病变处理指南新解

    • 版权声明：
    本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
    在此留言
    评论区 (7)
    #插入话题
    1. [GetPortalCommentsPageByObjectIdResponse(id=1715926, encodeId=6bc71e15926e3, content=<a href='/topic/show?id=2c375156e5f' target=_blank style='color:#2F92EE;'>#心脏瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51567, encryptionId=2c375156e5f, topicName=心脏瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b6d32099965, createdName=jianjun77, createdTime=Fri Feb 16 08:07:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267399, encodeId=6a9d126e399e0, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316068, encodeId=07d01316068c7, content=<a href='/topic/show?id=2c7b515e02e' target=_blank style='color:#2F92EE;'>#心脏瓣膜病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51570, encryptionId=2c7b515e02e, topicName=心脏瓣膜病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325344, encodeId=1d861325344d7, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486395, encodeId=771c148639525, content=<a href='/topic/show?id=b7192223389' target=_blank style='color:#2F92EE;'>#中文版翻译#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22233, encryptionId=b7192223389, topicName=中文版翻译)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf018125848, createdName=12498fa0m13暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583497, encodeId=a8e2158349e47, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68769, encryptionId=508d68e698c, topicName=瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58dc16986228, createdName=12498e5fm17(暂无昵称), createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178566, encodeId=ab7c1e856664, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Mar 04 11:19:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
      2018-02-16 jianjun77

      #心脏瓣膜#

      0

    2. [GetPortalCommentsPageByObjectIdResponse(id=1715926, encodeId=6bc71e15926e3, content=<a href='/topic/show?id=2c375156e5f' target=_blank style='color:#2F92EE;'>#心脏瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51567, encryptionId=2c375156e5f, topicName=心脏瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b6d32099965, createdName=jianjun77, createdTime=Fri Feb 16 08:07:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267399, encodeId=6a9d126e399e0, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316068, encodeId=07d01316068c7, content=<a href='/topic/show?id=2c7b515e02e' target=_blank style='color:#2F92EE;'>#心脏瓣膜病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51570, encryptionId=2c7b515e02e, topicName=心脏瓣膜病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325344, encodeId=1d861325344d7, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486395, encodeId=771c148639525, content=<a href='/topic/show?id=b7192223389' target=_blank style='color:#2F92EE;'>#中文版翻译#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22233, encryptionId=b7192223389, topicName=中文版翻译)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf018125848, createdName=12498fa0m13暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583497, encodeId=a8e2158349e47, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68769, encryptionId=508d68e698c, topicName=瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58dc16986228, createdName=12498e5fm17(暂无昵称), createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178566, encodeId=ab7c1e856664, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Mar 04 11:19:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
      2017-03-05 zhaohui6731

      #AHA#

      0

    3. [GetPortalCommentsPageByObjectIdResponse(id=1715926, encodeId=6bc71e15926e3, content=<a href='/topic/show?id=2c375156e5f' target=_blank style='color:#2F92EE;'>#心脏瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51567, encryptionId=2c375156e5f, topicName=心脏瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b6d32099965, createdName=jianjun77, createdTime=Fri Feb 16 08:07:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267399, encodeId=6a9d126e399e0, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316068, encodeId=07d01316068c7, content=<a href='/topic/show?id=2c7b515e02e' target=_blank style='color:#2F92EE;'>#心脏瓣膜病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51570, encryptionId=2c7b515e02e, topicName=心脏瓣膜病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325344, encodeId=1d861325344d7, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486395, encodeId=771c148639525, content=<a href='/topic/show?id=b7192223389' target=_blank style='color:#2F92EE;'>#中文版翻译#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22233, encryptionId=b7192223389, topicName=中文版翻译)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf018125848, createdName=12498fa0m13暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583497, encodeId=a8e2158349e47, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68769, encryptionId=508d68e698c, topicName=瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58dc16986228, createdName=12498e5fm17(暂无昵称), createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178566, encodeId=ab7c1e856664, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Mar 04 11:19:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
      2017-03-05 weiz

      #心脏瓣膜病#

      0

    4. [GetPortalCommentsPageByObjectIdResponse(id=1715926, encodeId=6bc71e15926e3, content=<a href='/topic/show?id=2c375156e5f' target=_blank style='color:#2F92EE;'>#心脏瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51567, encryptionId=2c375156e5f, topicName=心脏瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b6d32099965, createdName=jianjun77, createdTime=Fri Feb 16 08:07:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267399, encodeId=6a9d126e399e0, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316068, encodeId=07d01316068c7, content=<a href='/topic/show?id=2c7b515e02e' target=_blank style='color:#2F92EE;'>#心脏瓣膜病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51570, encryptionId=2c7b515e02e, topicName=心脏瓣膜病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325344, encodeId=1d861325344d7, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486395, encodeId=771c148639525, content=<a href='/topic/show?id=b7192223389' target=_blank style='color:#2F92EE;'>#中文版翻译#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22233, encryptionId=b7192223389, topicName=中文版翻译)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf018125848, createdName=12498fa0m13暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583497, encodeId=a8e2158349e47, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68769, encryptionId=508d68e698c, topicName=瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58dc16986228, createdName=12498e5fm17(暂无昵称), createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178566, encodeId=ab7c1e856664, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Mar 04 11:19:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
      2017-03-05 12498568m50暂无昵称

      #ACC#

      0

    5. [GetPortalCommentsPageByObjectIdResponse(id=1715926, encodeId=6bc71e15926e3, content=<a href='/topic/show?id=2c375156e5f' target=_blank style='color:#2F92EE;'>#心脏瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51567, encryptionId=2c375156e5f, topicName=心脏瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b6d32099965, createdName=jianjun77, createdTime=Fri Feb 16 08:07:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267399, encodeId=6a9d126e399e0, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316068, encodeId=07d01316068c7, content=<a href='/topic/show?id=2c7b515e02e' target=_blank style='color:#2F92EE;'>#心脏瓣膜病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51570, encryptionId=2c7b515e02e, topicName=心脏瓣膜病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325344, encodeId=1d861325344d7, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486395, encodeId=771c148639525, content=<a href='/topic/show?id=b7192223389' target=_blank style='color:#2F92EE;'>#中文版翻译#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22233, encryptionId=b7192223389, topicName=中文版翻译)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf018125848, createdName=12498fa0m13暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583497, encodeId=a8e2158349e47, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68769, encryptionId=508d68e698c, topicName=瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58dc16986228, createdName=12498e5fm17(暂无昵称), createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178566, encodeId=ab7c1e856664, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Mar 04 11:19:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
      2017-03-05 12498fa0m13暂无昵称

      #中文版翻译#

      0

    6. [GetPortalCommentsPageByObjectIdResponse(id=1715926, encodeId=6bc71e15926e3, content=<a href='/topic/show?id=2c375156e5f' target=_blank style='color:#2F92EE;'>#心脏瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51567, encryptionId=2c375156e5f, topicName=心脏瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b6d32099965, createdName=jianjun77, createdTime=Fri Feb 16 08:07:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267399, encodeId=6a9d126e399e0, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316068, encodeId=07d01316068c7, content=<a href='/topic/show?id=2c7b515e02e' target=_blank style='color:#2F92EE;'>#心脏瓣膜病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51570, encryptionId=2c7b515e02e, topicName=心脏瓣膜病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325344, encodeId=1d861325344d7, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486395, encodeId=771c148639525, content=<a href='/topic/show?id=b7192223389' target=_blank style='color:#2F92EE;'>#中文版翻译#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22233, encryptionId=b7192223389, topicName=中文版翻译)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf018125848, createdName=12498fa0m13暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583497, encodeId=a8e2158349e47, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68769, encryptionId=508d68e698c, topicName=瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58dc16986228, createdName=12498e5fm17(暂无昵称), createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178566, encodeId=ab7c1e856664, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Mar 04 11:19:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
      2017-03-05 12498e5fm17(暂无昵称)

      #瓣膜#

      0

    7. [GetPortalCommentsPageByObjectIdResponse(id=1715926, encodeId=6bc71e15926e3, content=<a href='/topic/show?id=2c375156e5f' target=_blank style='color:#2F92EE;'>#心脏瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51567, encryptionId=2c375156e5f, topicName=心脏瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b6d32099965, createdName=jianjun77, createdTime=Fri Feb 16 08:07:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267399, encodeId=6a9d126e399e0, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1316068, encodeId=07d01316068c7, content=<a href='/topic/show?id=2c7b515e02e' target=_blank style='color:#2F92EE;'>#心脏瓣膜病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51570, encryptionId=2c7b515e02e, topicName=心脏瓣膜病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1c77441, createdName=weiz, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325344, encodeId=1d861325344d7, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486395, encodeId=771c148639525, content=<a href='/topic/show?id=b7192223389' target=_blank style='color:#2F92EE;'>#中文版翻译#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22233, encryptionId=b7192223389, topicName=中文版翻译)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf018125848, createdName=12498fa0m13暂无昵称, createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1583497, encodeId=a8e2158349e47, content=<a href='/topic/show?id=508d68e698c' target=_blank style='color:#2F92EE;'>#瓣膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68769, encryptionId=508d68e698c, topicName=瓣膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58dc16986228, createdName=12498e5fm17(暂无昵称), createdTime=Sun Mar 05 08:07:00 CST 2017, time=2017-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=178566, encodeId=ab7c1e856664, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K46ZAxBHmHsph32KkfsWGwmickB6RsCUD8KruE4vo5CpvXfdu16GBpp4ibh6WJu1o9iatP1LWKDmvmic/0, createdBy=be6f1940165, createdName=1e0ece0dm09(暂无匿称), createdTime=Sat Mar 04 11:19:00 CST 2017, time=2017-03-04, status=1, ipAttribution=)]
      2017-03-04 1e0ece0dm09(暂无匿称)

      谢谢分享

      0

    相关资讯

    2014年AHA/ACC心脏瓣膜病指南10大亮点

    2014年3月，美国心脏病学会（ACC）与美国心脏协会（AHA）联合美国胸外科协会（AATS）、美国超声心动图学会（ASE）、美国心血管造影和介入协会（SCAI）、美国心血管麻醉师协会（SCA）和美国胸外科医师协会（STS）发布了《2014年心脏瓣膜病患者管理指南》。新指南较2006年和2008年的旧指南作了多处重要修改，为方便相关专业人员学习，ACC网站近期列出了新指南中的10条重大变化。

    退行性瓣膜病超声诊疗进展

    在发达国家，退行性变和器质性变是导致二尖瓣反流的主要原因。随着我国经济的逐渐发展，风湿性疾病逐渐得到控制，人口老龄化愈发严重，退行性瓣膜病越来越常见。本篇综述将就常见的退行性瓣膜病的病因学、流行病学、病理生理学、常见分型的超声诊断及治疗进展进行阐述。 1病因学及流行病学 在西方国家，因二尖瓣反流（Mitral valve regurgitation，MR

    胸腔镜下瓣膜成形及置换术

    　心脏瓣膜病是由多种原因引起的单个或多个瓣膜结构的功能或结构异常，导致瓣某狭窄和（或）关闭不全，患者表现为心慌、气促，治疗时需采取瓣膜成形手术和置换手术。

    Heart：临床资料对心脏瓣膜病的死后诊断敏感性较低

    生前临床信息记录对经尸检确定的死因具有高度特异性，但是相对不敏感。基于人群的死亡统计，取决于生前临床信息可能经常低估了VHD的死亡负担。

    心脏瓣膜病介入治疗进展

    关键词：经导管；瓣膜病；介入治疗 摘要：随着人口老龄化的到来，心脏瓣膜病的发病率明显增加。对于那些高龄、多种合并症的患者，开胸手术治疗的风险很大。近年来，经导管心脏瓣膜置换、修复术因其无需开胸、创伤小等优点得到了快速发展，已成为心血管疾病介入治疗领域新的热点，现通过复习相关文献对该技术的应用现状及研究进展做一介绍。 Advanced Progress of Transcatheter Valv